Skip to main content
National Patient Survey 2024 logo.Our National Patient Survey 2024 report is now live. Thank you to all those that shared their experiences. Read our report here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Pituitary Hormone Deficiency, Combined or Isolated, 1 (CPHD1) approved 613038
Pituitary Hormone Deficiency, Combined or Isolated, 2 (CPHD2) approved 262600
Pituitary Hormone Deficiency, Combined or Isolated, 2 (CPHD3) approved 600577
Pituitary Hormone Deficiency, Combined, 4 (CPHD4) approved 602146
Pituitary Hormone Deficiency, Combined, 5 (CPHD5) approved 601802
Pituitary Hormone Deficiency, Combined, 6 (CPHD6) approved 600037
Platelet Disorder, Familial, with Associated Myeloid Malignancy (FPDMM) approved 601399
Pleuropulmonary Blastoma (PPB) approved 601200
Poirier-Bienvenu Neurodevelopmental Syndrome (POBINDS) approved 618732
Polycystic Kidney Disease 1 with or without Polycystic Liver Disease (PKD1) approved 173900
Polycystic Kidney Disease 2 with or without Polycystic Liver Disease (PKD2) approved 613095
Polycystic Kidney Disease 3 with or without Polycystic Liver Disease (PKD3) approved 600666
Polycystic Kidney Disease 4 with or without Polycystic Liver Disease (PKD4) approved 263200
Polycystic Kidney Disease 5 (PKD5) approved 617610
Polycystic Kidney Disease 6 with or without Polycystic Liver Disease (PKD6) approved 618061
Polymicrogyria in association with homozygous/compound heterozygous ATP1A2 variants (autosomal recessive) approved *182340
Pontocerebellar Hypoplasia, Hypotonia, and Respiratory Insufficiency Syndrome, Neonatal Lethal (PHRINL) approved 618810
Pontocerebellar Hypoplasia, Type 1A (PCH1A) approved 607596
Pontocerebellar Hypoplasia, Type 1B (PCH1B) approved 614678
Pontocerebellar Hypoplasia, Type 2A (PCH2A) approved 277470